PGR and leiomyosarcoma: Ac-cording to Hwang et al. [20], an ER (+)/PR (+)/CD10 (+)/GEM (−)/h-caldesmon (−)/transgelin (−) im-munoprofile reliably distinguishes LG-ESS from uterine leiomyosarcoma [18,19,20,45,46,47].